I.A. Kilichev

8 ta ish

Toshkent Tibbiyot Akademiyasi

1. The Clinical-Haemodynamical Peculiarities of Ischemic Strokes with Underlying Symptomatic Arterial Hypertension

   Г. У. Оллаберганова, I.A. Kilichev

   MaqolaOAOchiq kirishNeurological Disorders and TreatmentsNATIONAL JOURNAL OF NEUROLOGY20180 iqtibos

   ABIABI:AkademIndex/2018.article.001240

2. Efficiency of comprehensive rehabilitation of chronic fatigue syndrome due to coronavirus infections COVID-19

   Z.I. Adambaev, I.A. Kilichev, A.B. Nurzhonov +2

   MaqolaOAOchiq kirishLong-Term Effects of COVID-19BIO Web of Conferences20230 iqtibos

   ABIABI:AkademIndex/2023.article.002905

3. Register of stroke in the desert-steppe zones of Uzbekistan

   I.A. Kilichev, Murod Matyokubov, Z.I. Adambaev +2

   MaqolaOAOchiq kirishBiomarkers in Disease MechanismsBIO Web of Conferences20230 iqtibos

   ABIABI:AkademIndex/2023.article.003227

4. Influence of comorbid diseases in the elderly on the efficiency complex conservative of pain in efficacy of treatment of back pain in the elderly with comorbidities

   Z.I. Adambaev, I.A. Kilichev, Z.O. Boltaeva +2

   MaqolaOAOchiq kirishMusculoskeletal pain and rehabilitationBIO Web of Conferences20230 iqtibos

   ABIABI:AkademIndex/2023.article.010266

5. Pathogenetic aspects of the effects of changes in the geomagnetic field on the vegetative regulation and the risk of vascular disorders

   N.Yu. Khudayberganov, Z.I. Adambaev, I.A. Kilichev

   MaqolaHeart Rate Variability and Autonomic ControlS S Korsakov Journal of Neurology and Psychiatry20250 iqtibos

   ABIABI:AkademIndex/2025.article.008832

6. Comparison of the effects of transcranial magnetic stimulation and memantine on motor aphasia in ischemic stroke patients

   A.U. Yusupov, I.A. Kilichev, N.Y. Khudayberganov

   MaqolaTranscranial Magnetic Stimulation StudiesS S Korsakov Journal of Neurology and Psychiatry20250 iqtibos

   ABIABI:AkademIndex/2025.article.017083

7. Serum ferritin, neutrophil-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio are associated with levodopa-induced dyskinesia severity in Parkinson’s disease

   F.S. Saidvaliyev, Dilyora Pulatova, I.A. Kilichev +8

   MaqolaOAOchiq kirishParkinson's Disease Mechanisms and TreatmentsBMC Neurology20260 iqtibos

   ABIABI:AkademIndex/2026.article.016672

8. Peripheral Iron and Immune Markers Are Associated With Levodopa-Induced Dyskinesia Severity in Parkinson’s Disease

   F.S. Saidvaliyev, Dilyora Pulatova, I.A. Kilichev +8

   PreprintParkinson's Disease Mechanisms and TreatmentsResearch Square20260 iqtibos

   ABIABI:AkademIndex/2026.preprint.000840